Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy. Schernberg, A.; Blanchard, P.; Chargari, C.; Ou, D.; Levy, A.; Gorphe, P.; Breuskin, I.; Atallah, S.; Caula, A.; Escande, A.; Janot, F.; Nguyen, F.; Temam, S.; Deutsch, E.; Tao, Y.. Clin Transl Radiat Oncol. 2018; 8-15: p.8-15. doi:10.1016/j.ctro.2018.07.002Article